# Bioam Gestion

Bioam Gestion is an Asset Manager based in Paris, France.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** Paris, France
- **Region:** Europe
- **Address:** Paris, France
- **Founded:** 1998
- **Assets under management:** Undisclosed
- **Website:** bioam.fr

## Regulatory record

- **Reports private funds:** No

## About

Bioam Gestion is a venture capital firm founded in 2000. It manages €56 million through two funds (FCPR) focused on biotechnology and life sciences investments. The firm has invested in over 10 early-stage companies and made 18 investments, including a Series D investment in Cytheris on June 24, 2010.

## Sectors

- Life Sciences
- Healthcare Services
- Digital Health
- AgriTech & FoodTech

## People

- Olivier de Fougeroux — Président

## Questions

### Which sectors does Bioam Gestion explicitly focus on?

The firm concentrates on three sub-verticals: biotechnology, including gene and cell therapies; medical technology, such as non-invasive surgical devices; and digital health. Its historical funds have also included mandates for rare diseases and agricultural biology, per the firm's official investment descriptions.

### How is Bioam Gestion related to the broader French asset management landscape?

Bioam is one of a small number of dedicated life sciences venture capital managers headquartered in Paris, distinct from larger French multi-asset managers that run health-sector sleeves within diversified funds. It operates independently and is not a subsidiary of a banking group or insurance conglomerate.

### Who runs investment decisions at Bioam Gestion?

Olivier de Fougeroux, the founder and president, leads the investment team. Public records and fund documentation list him as the central decision-maker since the firm's inception in 1998, though the full composition of the investment committee is not publicly detailed.

### Does Bioam Gestion participate in fund commitments or only direct deals?

Bioam Gestion invests directly into private European life sciences companies. There is no public record of the firm operating as a fund-of-funds or making LP commitments to other venture capital managers.

## Related profiles

- [Start-up Australia](https://altss.com/profile/start-up-australia)

---

Updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/bioam-gestion

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology